Carbetocin shortage — CA supply status & alternatives

Carbetocin

—

🇦🇺 AUST R 233671 · Ferring Pharmaceuticals Pty Ltd

Limited supply · Australia

In declared shortage · 🇦🇺 Australia & also short in🇨🇦 CA

Limited supply

Available

Reading today’s signals…

• Can I substitute?

No pathway on record

prescriber decision required

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

Apr 2026

Sponsor est. via TGA — may differ by brand

Product attributes reference data we hold

Active ingredient (INN)	Carbetocin
Therapeutic category	Auto-created by Health Canada — Drug Shortages Database scraper
Controlled substance	No

Marketing-authorisation holders	CONSILIENT HEALTH LIMITED, FARMAK PHARMACEUTICALS UK LTD, Ferring Pharmaceuticals Pty Ltd, Interpharma Pty Ltd +1 more

Registrations on file	5

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 1 resolved event

◷

~1 month

Historical pattern from resolved shortage records — not a prediction of this event.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

2 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

High concentration risk✓ 1 WHO-prequalified

Harbin Jixianglong Biotech CO LTDPiramal Pharma Limited

Manufacturing countries: China, India · Source: FDA List of Drug Master Files

Shortage status by regulator official notices

🇨🇦

Canada

HC · 4h ago

High

🇦🇺

Australia

TGA · just now

Medium

Verified timeline regulator events

🇦🇺 16 Mar 2026

medium reported

🇦🇺 12 Mar 2026

Shortage resolved

🇨🇦 25 Nov 2025

high reported

Sources official regulators

🇦🇺

TGA

verified just now

verify ↗

🇨🇦

verified 4h ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders5 registrations · 5 MA holders

Product	Strength	Form	Market	MA holder	Status
CARBETOCIN 100 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE	100 MICROGRAM	injection	🇬🇧 GB	CONSILIENT HEALTH LIMITED	Active
CARBETOCIN 100 MICROGRAMS/ML SOLUTION FOR INJECTION	100 MICROGRAM	injection	🇬🇧 GB	FARMAK PHARMACEUTICALS UK LTD	Active
DURATOCIN carbetocin	100 microgram	—	🇦🇺 AU	Ferring Pharmaceuticals Pty Ltd	Active
Interpharma	100 microgram	—	🇦🇺 AU	Interpharma Pty Ltd	Active
CARBETOCIN INJECTION	—	solution	🇨🇦 CA	JUNO PHARMACEUTICALS CORP.	Active

Mederti Drug Report

Generated 6 July 2026 · Australia market · 2 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.